Listed equity
Alkem Laboratories
एप्कोटैक्स इंड. · એપ્કોટેક્સ ઇન્ડ.
₹517.95▲₹0.90(+0.17%)
EOD close · 3 Jul 2026
mid rallyaccumulation +40
Trend and delivery agree: the price is rising and high-conviction buyers are taking delivery. Strength with substance.
52W low ₹310.1552W high ₹579.20
Now at 77% of its 52-week range
Long-term returns
1Y
+32.0%
3Y
-2.3%
5Y
+65.6%
10Y
+244.7%
Phase indicator
mid rally-10.6% from 52w high
Above 50- and 200-day MAs with +49.1% over 3 months — established uptrend.
1M
+5.5%
3M
+49.1%
1Y
+32.0%
Delivery conviction
accumulationscore +40
Delivery vs 20-day avg1.36x
Lifetime story
Alkem Laboratories is up 54421.1% from its lifetime low of ₹0.95 on 31 Jul 2001. ₹10,000 invested then would be worth ₹54,52,105 today (28.8% CAGR over 24.9 years). Lifetime high of ₹678.00 was set on 2 Jun 2022 (currently -23.6% below).
Fundamentals
Standalone vs consolidated — most retail products show only one. Consolidated includes subsidiary contribution.
3% premium to industry(Industry P/E 26.0)
| Standalone | Consolidated | |
|---|---|---|
| P/E (TTM)subs material | 26.81 | 72.52 |
| P/Bsubs material | 4.38 | 14.53 |
| Price / Cash flowsubs material | 18.01 | 57.94 |
| Dividend yield | 1.53% | 1.53% |
| Book value / sharesubs material | 119.78 ₹ | 36.10 ₹ |
| EPS (TTM)subs material | 19.56 ₹ | 7.23 ₹ |
Market cap
₹2.7K Cr
52W high
₹579.20
15 Jun 2026
52W low
₹310.15
30 Mar 2026
Returns ladder
1W
+2.4%
1M
+5.5%
3M
+49.1%
6M
+42.0%
YTD
+40.3%
1Y
+32.0%
3Y
-2.3%
5Y
+65.6%
10Y
+244.7%
Since listing
+10000.0%